Skip to content

Washington, D.C. · Nonprofit

Albert B Sabin Vaccine Institute Inc

Albert B Sabin Vaccine Institute Inc (Washington, D.C.) receives grants from 16 organizations whose IRS filings report $58,305,056 to it, the largest being GATES FOUNDATION ($28,339,945). 7 of them have funded it in more than one year.

Revenue FY2024
$36M
Funders on record
16
Grants received
$58M
Net assets
$8.4M
7/16 repeat fundersgrants exceed reported revenue in one year
01What it does

What Albert B Sabin Vaccine Institute Inc does

Mission

To make vaccines more accessible, enable innovation and expand immunization across the globe.

As stated on its FY2024 Form 990.

Programs

  1. Vaccine Research & DevelopmentThe Sabin Vaccine Institute supports innovative technologies and approaches in vaccine research and development to combat infectious and emerging threats to global health. Sabin's Research & Development strategy is to advance the development of vaccine candidates that have demonstrated early scientific value but have little commercial value, targeting diseases that impact the world's most vulnerable populations. Sabin leverages the expertise of partners in the academic, public, and private sectors, and promotes open-source research. Ebola has taken the lives of more than 15,000 people in the last many years. To protect communities across the globe from the critical threat posed by Ebola and the closely related, but lesser known, Marburg virus, Sabin is currently developing vaccines for Sudan ebolavirus and Marburg virus diseases based on technology licensed from GSK. The prophylactic vaccine candidates are based on GSK's proprietary ChAd3 platform. In 2019, the U.S. Health and Human Services' Biomedical Advanced Research and Development Authority awarded Sabin a multi-year development contract to advance development of the Marburg and Sudan Ebola…

    $27,130,238 spent$31,913,858 earned by the program
    73% of program spending
  2. Global ImmunizationDespite scientific advances and international support, 1.5 million people still die each year from diseases that could have been prevented by immunization. Sabin has a vision of a future free from such preventable diseases. Reaching this goal requires efficient vaccine distribution, broad vaccine uptake and equitable access to vaccination services. Through advocacy, capacity development and social, behavioral, and epidemiological research, Sabin advances evidence-based strategies for improved distribution and uptake of vaccines. Sabin's Global Immunization programs focus on turning vaccines into vaccinations by ceding power, resources, and decision-making to community and national stakeholders. They build consensus to mobilize action through stakeholder consortiums and convenings; strengthen the capabilities of local immunization professionals to deliver vaccinations to remote and hard-to-reach settings; co-design implementation research studies with community-based investigators to highlight barriers for vaccine uptake; and apply epidemiology for disease surveillance as well as optimizing vaccine use. Sabin's Boost global community enables immunization…

    $10,155,299 spentof which $3,064,520 as grants$7,417,901 earned by the program
    27% of program spending

The 2 programs described on its FY2023 Form 990, listed largest first by expense. Program spending in total: $37,285,537.

02The organization over time

The organization over time

Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.

100 = 20172017 Revenue 100 ($8.1M) Expenses 100 ($11M) Net assets 100 ($13M)2018 Revenue 129 ($10M) Expenses 99 ($10M) Net assets 100 ($13M)2019 Revenue 118 ($9.5M) Expenses 130 ($14M) Net assets 68 ($8.9M)2020 Revenue 286 ($23M) Expenses 197 ($21M) Net assets 87 ($11M)2021 Revenue 331 ($27M) Expenses 248 ($26M) Net assets 93 ($12M)2022 Revenue 413 ($34M) Expenses 296 ($31M) Net assets 110 ($14M)2023 Revenue 494 ($40M) Expenses 399 ($42M) Net assets 94 ($12M)2024 Revenue 442 ($36M) Expenses 377 ($40M) Net assets 64 ($8.4M)
'17'18'19'20'21'22'23'24
Revenue (442)Expenses (377)Net assets (64)Peer revenue range

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2022 to 2023, from $22M to $15M (−29%).

$15M
$16M
$13M
$16M
$19M
$22M
$15M
$14M
'17'18'19'20'21'22'23'24
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2017
2018
2019
2020
2021
2022
2023
2024
ContributionsProgram revenueInvestmentOther

Government-grant reliance: 2017 7% · 2018 3% · 2019 16% · 2020 52% · 2021 63% · 2022 64%. Grants only. Government contracts and fees sit inside program revenue.

0% of Albert B Sabin Vaccine Institute Inc’s revenue is contributions — more earned-revenue than three-quarters of its peers (26% for the typical peer).

This organization
Typical peer · 149 orgs

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 4 of the last 8 reported years ran a deficit.

−$2.4M
’17
$49k
’18
−$4.2M
’19
$2.4M
’20
$728k
’21
$2.3M
’22
−$2.0M
’23
−$4.0M
’24
1.3
months of
reserve

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

Chief executive

Finan Amy

CEO

Board chair

Rabinovich Regina

Trustee, Chair

As listed on its FY2024 Form 990.

The chief executive listed changed between the FY2017 and FY2018 filings.

'17'18'19'20'21'22'23'24
Listed2215192021211923
Joined·+15+7+6+5+5+2+5
No longer listed·22354541
03Who funds it

Who funds it, year by year

2017 → 2023: the base narrowed from 8 funders to 5 funders, grant income rose $2.7M → $4.9M.

5 of 16 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 36% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.

From the IRS filings of Albert B Sabin Vaccine Institute Inc’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How concentrated its funding is

Albert B Sabin Vaccine Institute Inc leans on a few funders — its largest provides 49% of grant income and the top three 95%; half comes from just 2 funders.

the vertical line marks half of all grant income — 2 funders to its left

51% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund Albert B Sabin Vaccine Institute Inc.

49%
largest funder
95%
top three
~3
effective funders

Largest funder’s share by year: 2017 95% · 2018 64% · 2019 57% · 2020 61% · 2021 93% · 2022 36% · 2023 54% — diversifying over time.

“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How long its funders stay

25% of Albert B Sabin Vaccine Institute Inc's funders are still giving 3 years after their first grant; 44% give in more than one year at all.

first grant+1y+2y+3y+4y+5y+6y

Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.

Where its funders are

Albert B Sabin Vaccine Institute Inc draws 100% of its grant income from funders outside Washington, D.C., across 6 states in all.

WA
NY
MA
CA
NC
TX

In-state vs out-of-state, by year

’17
’18
’19
’20
’21
’22
’23
Washington, D.C. out of state home

Funder states come from each funder’s own filing. $21M arriving through sponsors registered in 5 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Against its field

Albert B Sabin Vaccine Institute Inc has grown faster than three-quarters of the 149 unclassified nonprofits its size.

Operating margin−11% · bottom quartile
Months of reserve1.3mo · below the median
Revenue growth (annualized)24% · top quartile

this organization peer median middle 50% of peers· 149 unclassified nonprofits $10M–$100M, FY2024

Government funding Albert B Sabin Vaccine Institute Inc receives

Grants and contracts to this organization from federal (USASpending) and state checkbooks, reconciled to its EIN. $1k on record.

State$1k
22
23
24
Top programs
  • REFUNDS - GENERAL $1k

Federal grants vs contracts are distinguished; state line items keep their reported category. Matched by name + geography (the BMF), so coverage is partial and precision-first.

Organizations like Albert B Sabin Vaccine Institute Inc

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

In Washington, D.C.

Nationally

05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Where the money goes

90% of spending goes to programs.

Program 90%Management 9%Fundraising 1%

Governance

14
board members
93%
independent
✓Conflict-of-interest policy✓Whistleblower policy✓Document retention✓Board reviewed the 990✓Audited financials

Public support

68%

Share of support from the public (Schedule A) — the basis for its public-charity status.

Footprint & structure

Files a return copy in 6 states

WA
NY
CA
MD
DC
FL

Screen this organization

A dated, signed PDF of the compliance screen for Albert B Sabin Vaccine Institute Inc: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds Albert B Sabin Vaccine Institute Inc?
Albert B Sabin Vaccine Institute Inc (Washington, D.C.) receives grants from 16 organizations whose IRS filings report $58,305,056 to it, the largest being GATES FOUNDATION ($28,339,945). 7 of them have funded it in more than one year.
How many funders does Albert B Sabin Vaccine Institute Inc have?
IRS filings report 16 organizations giving $58,305,056 in grants to Albert B Sabin Vaccine Institute Inc, 7 of which have funded it in more than one year.
Who is the largest funder of Albert B Sabin Vaccine Institute Inc?
GATES FOUNDATION is the largest funder on record, with $28,339,945 in grants. The full list of funders is on this page.
How can an organization like Albert B Sabin Vaccine Institute Inc find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in Washington, D.C.. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 16 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing